Search results
Results from the WOW.Com Content Network
Allkem Limited, known as Orocobre Limited until 30 November 2021, [1] is an Australian mining company that is a wholly-owned subsidiary of Arcadium Lithium.Allkem's portfolio includes lithium brine operations in Argentina, a hard-rock lithium operation in Australia and a lithium hydroxide conversion facility in Japan.
The S&P/ASX 300, or simply, ASX 300, is a stock market index of Australian stocks listed on the Australian Securities Exchange (ASX). The index is market-capitalisation weighted, meaning each company included is in proportion to the indexes total market value, and float-adjusted, meaning the index only considers shares available to public investors.
ANZ ETFS S&P/ASX 100 ETF S&P/ASX 100 Index AUS 0.24 ZYAU ANZ/ETF Securities: ANZ ETFS S&P/ASX 300 High Yield Plus ETF S&P/ASX Shareholder Yield Index AUS 0.35 IHCB BlackRock: iShares Core Global Corporate Bond (AUD Hedged) ETF Bloomberg Barclays Global Aggregate Corporate Bond Index (AUD Hedged) US 0.26 IHHY BlackRock
Galaxy Resources was a lithium mining company with projects in Australia, Canada and Argentina. [3]It owned and operated the Mt Cattlin spodumene-tantalite mine at Ravensthorpe, Western Australia. [3]
The side effects of bicalutamide, a nonsteroidal antiandrogen (NSAA), including its frequent and rare side effects, have been well-studied and characterized. The most common side effects of bicalutamide monotherapy in men include breast tenderness , breast growth , feminization , demasculinization , and hot flashes .
The S&P/ASX 20 index is a stock market index of stocks listed on the Australian Securities Exchange from Standard & Poor's. While the "ASX 20" often simply refers to the 20 largest companies by market capitalisation , the S&P/ASX 20 Index is calculated by using the S&P Dow Jones Indices market capitalization weighted and float-adjusted ...
Alkem has developed a portfolio of 705 branded generic drugs, with 13 of the brands featured among the top 300 brands in India for the fiscal year 2015 and a portfolio of 705 brands in India in the six months ended 30 September 2015.
This article needs more reliable medical references for verification or relies too heavily on primary sources, specifically: Unsourced list of side effects, needs references. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed